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Myostatin is a member of the transforming growth factor-β (TGF-β) super-family and functions as a negative regulator of 
muscle growth. Binding of the specific receptor, Activin receptor IIB (Act RIIB), with myostatin or other related TGF-β 
members, could be inhibited by the activin-binding protein follistatin (Fst) in mammals. Overexpressing Fst in mouse skeletal 
muscle leads to muscle hypertrophy and hyperplasia. To determine if Fst has similar roles in fish, we generated transgenic ze-
brafish expressing high levels of zebrafish Fst1 using the promoter of the zebrafish skeletal muscle-specific gene, myosin, light 
polypeptide 2, skeletal muscle (Mylz2). Independent transgenic zebrafish lines exhibited elevated expression levels of myo-
genic regulatory genes MyoD and Pax7 in muscle cells. Adult Fst1 overexpressing transgenic zebrafish exhibited a slight body 
weight increase. The high level of Fst1 expression dramatically increased myofiber numbers in skeletal muscle, without sig-
nificantly changing the fiber size. Our findings suggest that Fst1 overexpression can promote zebrafish muscle growth by en-
hancing myofiber hyperplasia. 
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Myostatin, a member of the transforming growth factor su-
per-family, has been shown to negatively regulate satellite cell 
growth and post-natal myogenesis through Pax7 signals [1]. 
Like other members of the TGF-β superfamily, myostatin is 
synthesized as a precursor protein consisting of a signal 
peptide, an amino-terminal propeptide domain (or prodo-
main) and a carboxy-terminal mature (active) domain. The 
precursor undergoes two proteolytic processing events by 
its proprotein convertases to generate the biologically active 
molecule. The precursor protein forms a homodimer before 
proteolytic processing. The cleaved propeptide molecule 
remains non-covalently bound to the mature domain dimer, 
forming a latent complex, which inhibits its biological ac-
tivity by inhibiting myostatin binding to its receptor. It has 
been reported that myostatin exhibits a pivotal role as a 
negative regulator of skeletal growth in zebrafish, as do its 
orthologs in higher vertebrates. In addition, transgenic ze-
brafish expressing the myostatin prodomain could increase 
the number of fibers in skeletal muscle [2–4].  
Follistatin (Fst) is a secreted glycoprotein that was first 
identified as a potent inhibitor of some members of the 
TGF-β super-family, because of its strong binding affinity 
for the receptor protein, activin [5,6]. It can also directly 
bind some TGF-β ligand proteins at lower affinities com-
pared to activin in mammals [6–8]. Fst can block the activ-
ity of growth differentiation factor (GDF-11) and myostatin 
via competitive binding. Fst knockout mice have reduced 
muscle mass at birth [9], whereas mice overexpressing Fst 
in skeletal muscle showed a gross increase in muscle fiber 
hyperplasia and hypertrophy, compared to wild-type ani-
mals [10,11]. 
The cyprinid zebrafish (Danio rerio) was recently shown 
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to have two Fst genes, Fst1 and Fst2. Fst1 is universal 
among teleosts, and is closely related to the single gene of 
higher vertebrates. During the embryonic stage, zebrafish 
Fst1 is initially expressed in the anterior somite before be-
coming restricted to the external cell layer. Furthermore, 
Fst1 is strongly expressed in the ventral region of rostral 
somites, which produces presumptive myogenic precursors 
of muscles, suggesting a potential role of Fst1 in myogene-
sis in cyprinids [12].  
Fst’s inhibitory function on GDFs and the enhanced 
muscle growth phenotypes caused by the overexpression of 
Fst in mice, prompted us to produce Fst1 overexpressing 
zebrafish, with the Fst1 driven by the mylz2 promoter, a 
strong zebrafish skeletal muscle-specific promoter [13]. The 
Fst1 transgenic zebrafish had only a slightly increased body 
weight; however, Fst1 overexpression indeed enhanced 
MyoD and Pax7 expression in adult transgenic fish skeletal 
muscle. Furthermore, skeletal muscle growth of the trans-
genic zebrafish overexpressing Fst1 was significantly en-
hanced, with a significant increase in numbers of myofibers. 
Thus, a negative regulatory role for Fst in myostatin-related 
hyperplasia of muscle in cyprinids is suggested, similar to 
its orthologs in amniotes.  
1  Materials and methods 
1.1  Transgenic construction 
The zebrafish mylz2:EGFP transgenic construct was previ-
ously described and kindly provided by Dr. Gong ZhiYuan 
from National University of Singapore [13]. The Tol2 en-
hancer trap vector described previously was kindly provided 
by Dr. Korzh V. of the Institute of Molecular and Cellular 
Biology in Singapore [14]. A fragment containing the mul-
tiple cloning site (MCS) and SV40 polyadenylation se-
quence from pCMV-HA vector (Clontech, PT3285, 
bp829-1049) was amplified using forward primer (5′-gg- 
atccaccatgtacccatacgatgttccagattacgct-3′) and reverse primer 
(5′-ggatcctttattgcagcttataatggtt-3′), which both contain a 
BamH I recognition site (underlined). The amplified frag-
ment was then cloned into BamH I-digested mylz2:EGFP to 
make our muscle expression intermediate vector. After a 
series of Xba I digestion, filling-in with the Klenow frag-
ment and self-ligation, we gradually destroyed the Xba I site 
within our intermediate construct. The fragment containing 
the mylz2 promoter region, the MCS, and SV40 polyade-
nylation sequence was then amplified with the forward 
primer (5′-aattcgccacagaggaatg-3′) and reverse primer (5′- 
tttattgcagcttataatggtt-3′), both containing an Xba I recogni-
tion sites. The amplified fragment was then cloned into Xba 
I-digested Tol2 enhancer trap vector to make our muscle 
specific promoter, and keratin8 basal promoter driven EGFP 
expression vector (MHK vector). This MHK vector contains 
an MCS originally from pCMV-HA vector. Finally, a 
full-length cDNA of zebrafish Fst1 was cloned via RT-PCR 
from a zebrafish embryonic total RNA sample. Two oli-
gonucleotide primers, forward primer (5′-atgaattcg- 
gatgctaaggatgctaaagcg-3′) containing a EcoR I recognition 
site (underlined), and reverse primer (5′-atctcgagctacttgtcgtc 
atcgtctttgtagtc ggcgcacacagcttcctccg-3′) containing a Xho I 
recognition site (underlined) and a tag peptide coding region 
(italic), were used to amplify a 0.9 kb of Fst1 coding region 
based on the zebrafish Fst1 mRNA deposited in GenBank 
(Accession No. NM_131037). The amplified Fst1 products 
were cloned into the MHK vector, where Fst1 expression 
was driven by the zebrafish mylz2 promoter. The SV40 
polyadenylation sequence for transcription termination of 
Fst1 expression was followed by an epithelial specific 
EGFP expression unit controlled by zebrafish keratin8 
promoter, which could be used as a linked reporter gene 
product for positive gene integration screening (Figure 1A). 
The Tol2 arms flanking the Mylz2 promoter, zebrafish Fst1 
coding region, SV40 polyadenylation sequence, keratin8 
promoter, EGFP coding region and SV40 polyadenylation 
sequence were used to enhance genome integration [14]. 
1.2  Production of transgenic fish  
The medaka transposase cDNA clone [14] was kindly 
provided by Dr. Korzh V. Ten nanograms of MHK-Fst1 
plasmid DNA with 25 ng of in vitro synthesized transpo-
sase mRNA was co-injected into zebrafish embryos at the 
one- or two-cell stage, as previously described by Parinov 
et al. [14]. Expression of GFP in the injected embryos was 
observed and photographed under a Leica fluorescence 
microscope. 
Injected embryos with epithelial EGFP expression were 
allowed to grow and cross with wild-type fish. For each F1 
cross, at least 100 embryos were examined under a fluores-
cence microscope. The presence of the transgene fragment 
was tested by PCR amplification using fish genomic DNA 
as the template and forward primer (within the mylz pro-
moter region) 5′-TCAGTGGCTACAGCTCATTCA-3′ and 
reverse primer (within the zfFst1 coding region) 5′- 
TTTGTCTGGTCCACCACGCAA-3′. The expected size of 
the amplified fragment was 981 bp. The identified trans-
genic founders were then crossed with wild-type fish for the 
analysis. 
1.3  Whole-mount in situ hybridization 
Whole-mount in situ hybridization using a digoxigenin 
(DIG)-labeled riboprobe was carried out as previously de-
scribed [15]. The zebrafish Fst1 cDNA clone was amplified 
as above and cloned into pBluescript vector [13]. The plas-
mid was linearized with BamH I, followed by an in vitro 
transcription reaction with T7 RNA polymerase to generate 
the antisense RNA probe. The embryos/larvae up to five 
days post fertilization (dpf) were fixed in 4% paraformal-
dehyde, and hybridized with the DIG-labeled riboprobe in  
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Figure 1  Generation of transgenic zebrafish. A, Transgenic construct containing 5' and 3' ends of Tol2 recombination arms at each end of the functional 
region. The functional region contains a 1.9 kb zebrafish myosin light polypeptide 2 (mylz2) promoter, the 0.9 kb zebrafish follistatin 1 (Fst1) coding region 
and SV 40 poly(A) signal, a 0.5 kb basal promoter of zebrafish keratin 8 (krt8), the 0.8 kb EGFP coding region and a SV 40 poly(A) signal. B, Fluorescence 
image of MHK-Fst1 injected embryos observed at 24 hpf. The embryos with EGFP expression in the skin indicated the successful delivery of the transgenic 
construct via microinjection. C, Fst1 expression observed in embryos injected with MHK-Fst1 at 48 hpf stages via whole mount in situ hybridization. Most 
of the Fst1 overexpression caused defects during embryonic development (as indicated with “b”, or “c”), while only a small proportion of injected embryos 
showed normal development (as indicated with “a”). D and E, Images of a transgenic founder under normal microscopy (D) and fluorescence microscopy 
(E). F, Fluorescence image of a batch of embryos from the cross between a wild-type and a stable transgenic founder. Embryonic expression of EGFP in the 
skin suggested a stable germline transmission. G, Insertion test using genomic DNA PCR tests. Amplified PCR fragments of the correct size and sequence 
are shown in lanes 2, 4, and 6 representing stable transgenic lines 1, 2, and 3. Their non-insertion containing control sibling DNAs are in lanes 1, 3, and 5. H, 
Comparison of Fst1 overexpression in skeletal muscle between transgenic zebrafish and controls at 60 dpf via real-time PCR. The data represents three rep-
licates in each transgenic line. a, transgenic larva with a normal development; b, dorsalizing patterning of some MHK-Fst1injected embryos; c, cessation of  
embryonic development in some MHK-Fst1 injected embryos. 
 
hybridization buffer [50% formamide, 5×SSC (1×=15 mmol 
L−1 NaCl, 15 mmol L−1 sodium citrate, pH 7.6), 50 mg 
heparin, 50 mg mL−1 tRNA and 0.1% Tween] at 70°C. They 
were then incubated with anti-DIG antibody conjugated 
with alkaline phosphatase and stained with nitroblue phos-
phate (NBT) and 5-bromo, 4-chloro, 3-indolil phosphate 
(BCIP) to produce purple and insoluble precipitates. 
1.4  RNA isolation and real-time PCR 
The levels of Fst1, MyoD and Pax7 in non-transgenic con-
trol or Fst1 transgenic fish were quantitatively analyzed 
using real-time PCR at 60 dpf. About 100 mg of muscle tis-
sue was used for total RNA extraction with Trizol reagent, 
following the procedure recommended by the manufacturer 
(Invitrogen). The total RNA was digested with RNase-free 
DNAase to remove endogenous DNA contamination. First-     
strand cDNA was synthesized by reverse transcriptase using  
a SuperScript®III platinum One-step qRT-PCR Kit (Invi-
trogen). Zebrafish Fst1, MyoD, and Pax7 were detected by 
amplification using gene-specific primers (Table 1). Ze-
brafish β-actin gene expression was also analyzed (produc-
ing a 102 bp amplified product) as an internal control using 
specific primers (Table 1). All amplicons were sequenced to 
confirm the desired products. 
Real-time PCR was carried out on a Sequence Detector 
(PRISM 7700; ABI, Foster City, CA, USA). Each reaction 
contained 2 μL cDNA and primers at a final concentration of 
2 ng μL−1. The samples were first heated to 50°C for 2 min, 
followed by 95°C for 10 min. The PCR reaction was carried 
out for 40 cycles of 95°C for 15 s and 60°C for 1 min. SDS 
v1.7a software was used to define the cycle in which each 
sample attained the threshold value. All values were com-
puted using a standard curve and normalized to zebrafish 
β-actin, which served the internal positive control. 
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Table 1  Primers for real-time RT PCR 
Gene Primer Primer sequence Size of amplicon 
Forward 5′-GACGTGTGATAATGTTGACTGTGG-3′ Zebrafish Fst1 
Reverse 5′-GCATTTGCCTTGATACTGGACCTC-3′ 
214 bp 
Forward 5′-CGCCATTAGTTATATCGAGTC-3′ Zebrafish MyoD 
Reverse 5′-CGTCATTGAAGTAAGAGCTG-3′ 
200 bp 
Forward 5′-ATAAGTTGCTGAAGGACGGAGTGT-3′ Zebrafish Pax7 
Reverse 5′-TCACACTCGTCATCGTCATCTTTC-3′ 
127 bp 





1.5  Growth evaluations and muscle histological analy-
sis  
To determine their body weights, all fish were weighted at 
30 and 60 dpf. For muscle histological analysis, muscle 
tissues from ten individual fish from each group at 60 dpf 
were fixed in Bouin’s solution for 10 h followed by rou-
tine paraffin sectioning and Hematoxilin/Eosin staining. 
Vertical sections at the base of the first pin of the pelvic 
fin were selected for quantification of the muscle fiber 
number.  
2  Results 
2.1  Generation of transgenic zebrafish  
The MHK-Fst1 plasmid constructs were co-injected with 
the synthesized medaka transposase mRNA into fish em-
bryos. Seventy-five percent of the injected embryos showed 
abnormal developmental features and died prior to hatching, 
possibly as a result of mis-expression of Fst1 during em-
bryonic stages (a representative features of MHK-Fst1 in-
jected F0 embryos are shown in Figure 1C, labeled as a, b, 
c). However, 45 fish survived to adulthood from among the 
180 injected embryos (Figures 1D and E). The transgenic 
founders (F0) were initially screened based on the epithelial 
EGFP-expression observed under fluorescence microscopy 
(Figures 1B and E). As a result, we obtained 28 F0 fish 
showing epithelial EGFP expression, and three of them 
showed germline transmission. Skeletal muscle Fst1-ex-     
pression was confirmed using a genomic DNA PCR test to 
ensure the correct insertion within the zebrafish genome. 
(Figure 1G). These germline transmitters were then used to 
produce F1 generations. The transmission rate of the trans-
gene into the F1 generation varied from 3%–7% (Figure 1F). 
Unlike initial embryos injected with the mylz:fst1 construct, 
the survival rates of all F1 transgenic strains were not sig-
nificantly difference from those of non-transgenic fish (Fig-
ures 1E and F). Using real-time PCR, we confirmed that the 
average relative expression level of Fst1 in 60 dpf trans-
genic fish skeletal muscle tissue was much higher than that 
in control zebrafish (Figure 1H): about six-fold higher in 
lines 2 and 3 than in their non-transgenic control sibling 
fish. 
2.2  Fish body weight  
To determine body weight, we weighed fish at 30 and 60 
dpf and compared transgenic fish with their control siblings. 
At 30 dpf, the body weights of the transgenic fish and the 
controls were not significantly different. However, at 60 dpf, 
the average body weight of our Fst1 hemizygous transgenic 
zebrafish had increased slightly, but significantly (by 
8.14%), compared with their non-transgenic sibling controls 
(Table 2). The observed phenotype was more obvious com-
pared that observed in hemizygous myostatin prodomain 
transgenic zebrafish, who showed no significant enhance-
ment in body mass [2]. This suggests that Fst1 overexpres-
sion has a stronger influence on body mass increase than 
myostatin prodomain overexpression. 
2.3  Myogenic gene expression levels in Fst1 overexpre-  
ssing transgenic zebrafish 
To determine if Fst1 overexpression enhances the expres-
sion of a myogenic regulatory gene, we analyzed the ex-
pression of MyoD in transgenic fish embryos by whole 
mount in situ hybridization. There was no significant 
change in MyoD expression in transgenic zebrafish at em-
bryonic stages (data not shown). However, at later stages 
(60 dpf), we analyzed the expression of MyoD and Pax7 in 
transgenic zebrafish by quantitative real time RT-PCR. The 
expression level of MyoD was significantly upregulated in 
Fst1 adult transgenic zebrafish skeletal muscle tissue com-
pared with its non-transgenic siblings (Figure 2). As MyoD, 
Pax7 appears to have critical roles as well during satellite 
cell activation, proliferation, and differentiation. The ex-
pression of Pax7 in fish muscle was enhanced in the Fst1 
overexpressing zebrafish muscle at 60 dpf stage (Figure 2). 
This result indicated that Fst1 overexpression in skeletal 
muscle could enhance myogenesis in zebrafish. 
2.4  Histological analysis of muscle growth  
To determine whether or not muscle growth was affected in 
the Fst1 transgenic fish, samples of representative trans-
genic fish and their non-transgenic siblings were sectioned 
to determine fiber size and number at 60 dpf (Figures 3A 
and B). The number of myofibers from a defined region of 
the epaxial muscle at the base of the first pin of the pelvic  
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Table 2  Body mass comparison between transgenic fish and non-transgenic siblings 
Control fish Fst transgenic fish 
Age 
Number Mass (g)a) 
 
Number Mass (g)a) 
P-valueb) 
30 dpf 11 0.03091±0.01004  4 0.02950±0.01489 0.05346 (>0.05) 
60 dpf 14 0.06957±0.02667  13 0.07523±0.01845 0.2652 (<0.05) 
a) Mass is shown as means±SE; b) P values are the result of a t-test. P< 0.05 indicates a significant difference. 
 
 
Figure 2  Comparison of myogenic gene MyoD and Pax7 expression in 
muscles of transgenic and control fish by real-time PCR. Total RNA was 
extracted from muscle tissue and real-time PCR was performed as de-
scribed in Materials and methods. Three individuals from each of trans-
genic line 2 and 3 were analyzed. The amount of MyoD and Pax7 mRNA 
analyzed was normalized to β-actin expression levels. Data are means±SD 
of transgenic and their non-transgenic sibling fish performed in triplicate. 
The levels of the MyoD and Pax7 expression are statistically significantly  
different as determined by a t-test. 
fin was determined by counting them under a microscope at 
a fixed magnification (Figures 3C, D, E, F, and G). The 
average number of fibers in Fst1 transgenic fish ((604.14 ± 
47.76), n=10) was much larger than the corresponding 
number in non-transgenic control fish ((462.63 ± 32.12), 
n=10). While a larger number of the myofibers observed in 
the same region of the muscle tissue of transgenic fish than 
the ones in control fish, the existence of many small diame-
ter fibers has also been seen obviously in the Fst1 trans-
genic muscle tissue (Figures 3D, E, F, and G). The average 
individual myofiber area from Fst1 transgenic zebrafish was 
not significantly larger than the same area from their control 
siblings. These results indicated that the enhanced muscle 
growth induced by Fst1 overexpression in zebrafish was 
caused by hyperplastic growth of muscle, not by hypertro-
phy. 
3  Discussion 
In this study, an Fst1 expression construct under the control 
of the fish skeletal muscle specific promoter, mylz2, was 
used to investigate the regulatory function of Fst1 in fish 
muscle development and its potential role in the regulation 
of fish muscle growth. Microinjection of the mylz2:fst1 
construct initially caused a large proportion (75%) of mal-
formations during early embryonic development, which 
might reflect the critical function of the Fst1 in dorsoventral 
patterning during zebrafish gastrulation [16]. The remaining  
 
Figure 3  Enhanced muscle growth via hyperplasia in Fst1 overexpres-
sion transgenic zebrafish. A and B, Pictures of killed and skinned trans-
genic (Tg) and their non-transgenic control sibling (con) zebrafish. The 
Fst1 overexpressing transgenic fish show the typical morphological feature 
of high and thick muscle tissue in the dorsal muscle region compared with 
their non-transgenic siblings. C, High magnification image showing the 
typical morphological feature of the Fst1 overexpressing transgenic fish. D 
and E, Low magnification pictures of cross-sections stained with hema-
toxylin and eosin of the transgenic (E) and control fish (D). F and G, High 
magnification images of the tissue region in the box indicated in panel of D, 
E. Histological analysis of Fst1 over-expressing fish indicated an increas-
ing number of myofibers in transgenic fish compared with their non-    
transgenic control siblings, based on the count and analysis of the number  
of myofibers in the box in panels F and G. 
25% of the mylz:fst1 injected embryos survived to adult-
hood, which might be because of the late and mus-
cle-specific expression properties of the mylz2 promoter. 
Our results revealed that muscle-specific Fst1 overexpres-
sion significantly enhanced fish muscling (Figure 3). The 
overexpression of Fst1 also stimulated MyoD and Pax7 ex-
pression in the skeletal muscle of transgenic fish (Figure 2). 
Histological analysis also suggested that enhanced skeletal 
muscle growth in the Fst1-overexpressing fish mainly re-
sulted from myofiber hyperplasia (Figure 3). 
One member of the TGF-β superfamily that has a major 
role in regulating muscle growth is myostatin. In mammals, 
homozygous deficiency of myostatin causes an impressive 
increase in muscle mass. Previously, myostatin activity ab-
lation in zebrafish, via RNAi and morpholino injection, also 
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led to a giant phenotype and the upregulation of some key 
myogenic transcriptional factors during embryonic somito-
genesis [3,4]. However, similarly to a previous transgenic 
study of myostatin prodomain overexpression [2], we failed 
to observe any obvious phenotypic differences or upregula-
tion of MyoD and myf5 in our Fst1-overexpressing trans-
genic fish until two weeks post-hatch (Table 2, or via whole 
mount in situ (data not shown)). However, similar to the 
results obtained in mice overexpressing Fst in skeletal mus-
cle [10], muscle growth in adult transgenic zebrafish did 
increase compared with non-transgenic control fish, indi-
cating increased muscle mass. We found no difference in 
body weight between transgenic and control animals at the 
hatching stage, and only a moderate increase in body weight 
in hemizygous Fst1-overexpressing transgenic fish (Table 
2). In contrast to the giant zebrafish phenotype obtained by 
the ubiquitous inhibition of myostatin activity through egg 
microinjection, muscle specific inhibition of myostatin or 
other potential regulatory TGF-β members using the trans-
genic method seems to show mild effects on body growth. 
This might be related to late Fst1 overexpression from the 
Mylz2 promoter, whose transcription is initiated only from 
20 hpf [13]. It might also suggest that fish myostatin has a 
substantial body mass regulation function beyond that in 
muscle tissue. It has been speculated that Fst1 might block 
other Fst-sensitive ligands expressed in muscle tissue, such 
as growth and differentiation factor-11 (GDF-11, 11, 7, 8). 
Previous studies demonstrated that Fst transgenic mice had 
larger muscle mass increases than transgenic mice overex-
pressing the dominant negative form the activin receptor B 
and myostatin prodomain [10,17]. The expression level of 
MyoD increased in our adult mylz2:Fst1 transgenic fish, 
which was not observed in myostatin prodomain-overex-    
pressing transgenic zebrafish [2]. Strong muscling in our 
mylz2:Fst1 transgenic fish was observed in our histological 
analysis. Phenotypes related to muscle growth seemed more 
significant in our Fst1 overexpressing fish compared to the 
transgenic zebrafish expressing the myostatin prodomain [2]. 
This might reflect the stronger effect of Fst1 on muscle 
growth promotion than the myostatin prodomain protein, 
because Fst has been suggested to be involved in the inhibi-
tion of TGF-β members other than myostatin [7,18].  
Lack of myostatin could lead to an enhanced level of 
Pax7 expression or an increased number of Pax7-positive 
muscle precursor cells. It has been suggested that myostatin 
signals through Pax7 to regulate the pool of muscle precur-
sors [1]. In the present study, we demonstrated that Pax7 
expression in skeletal muscle was enhanced by Fst1 over-
expression (Figure 2). Compared with the 10% increase in 
myofiber number in myostatin prodomain protein transgenic 
zebrafish described by Xu et al. [2], Fst1-overexpressing 
transgenic fish exhibited a 33% increase in numbers of fi-
bers. The proportion of small-diameter fibers in our Fst1 
transgenic zebrafish is higher than that observed in their 
control siblings (Figure 3), indicating enhanced post-hatch 
myogenic proliferation or stratified hyperplasia. However, 
we observed a <10% body weight increase and no obvious 
fish size difference between Fst1 transgenic fish and con-
trols. This might be because of the non-homozygous back-
ground of the transgenic fish that we analyzed. Fst overex-
pressing mice showed reproductive difficulties [19], and we 
also encountered reproductive difficulties in our Fst1 trans-
genic zebrafish. We have not yet been able to obtain homo-
zygous Fst1 transgenic zebrafish. This might be because of 
the different mechanisms adopted for modulation of post-
natal muscle growth between teleosts and amniotes, in 
terms of the contributions of hypertrophy or hyperplasia to 
muscle growth [20]. Muscle mass growth in vertebrates 
increases by the recruitment of new muscle fibers (hyper-
plasia), as well as by increasing the size of already existing 
fibers (hypertrophy) [20,21]. However, small and slow-    
growing fish, like zebrafish, largely rely on stratified hyper-
plasia; this could explain the low capacity of the Fst trans-
genic fish to further increase their body size, even with sig-
nificantly increased stratified hyperplasia.  
The production of an F0 generation of Fst-overexpress-    
ing transgenic trout was recently reported [22]. Fst overex-
pression in the muscle of the F0 transgenic trout resulted in 
increased muscling, almost exclusively by muscle fiber hy-
perplasia. Our observation of the effect of Fst overexpres-
sion on muscle mass is similar to previous studies on pro-
myostatin transgenic zebrafish and Fst transgenic trout [2,22]. 
Nevertheless, the present study demonstrated, in vivo, that 
muscle-specific Fst1 overexpression in zebrafish could en-
hance muscle growth by upregulating the expression of 
myogenic factors and enhancing myofiber hyperplasia, 
probably via negative regulation of the function(s) of my-
ostatin and/or other members of the TGF-β super-family. 
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